Effect of Empagliflozin on Left Ventricular Mass and Diastolic Function in Individuals With Diabetes: An Important Clue to the EMPA-REG OUTCOME Trial?

Subodh Verma, Ankit Garg, Andrew T. Yan, Anup K. Gupta, Mohammed Al-Omran, Andre Sabongui, Hwee Teoh, C. David Mazer, Kim A. Connelly
Dec 1, 2016; 39:212-213
e-Letters: Observations
Diabetes Care: Most-Read Full-Text Articles





  • Twitter
  • del.icio.us
  • Digg
  • Facebook
  • Technorati
  • Reddit
  • Yahoo Buzz
  • StumbleUpon

Leave a Reply

Your email address will not be published. Required fields are marked *